European Journal of Hospital Pharmacy: Science and Practice最新文献

筛选
英文 中文
5PSQ-141 Analysis of ceftaroline associated neutropenia 5PSQ-141头孢他林相关性中性粒细胞减少症分析
European Journal of Hospital Pharmacy: Science and Practice Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.260
L. García Basas, A. Gago, J. Sáez De La Fuente, AM Álvarez Díaz
{"title":"5PSQ-141 Analysis of ceftaroline associated neutropenia","authors":"L. García Basas, A. Gago, J. Sáez De La Fuente, AM Álvarez Díaz","doi":"10.1136/EJHPHARM-2021-EAHPCONF.260","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.260","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85573034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
5PSQ-209 Anticholinergic burden and risk of adverse events in patients from a Spanish nursing home 5PSQ-209西班牙养老院患者抗胆碱能负担和不良事件风险
European Journal of Hospital Pharmacy: Science and Practice Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.328
H. Rodríguez Ramallo, E. Prado Mel, R. Ramos Romero, MI Galván-Borrás, JC Huarte Mendicoa, B. Fernandez Rubio
{"title":"5PSQ-209 Anticholinergic burden and risk of adverse events in patients from a Spanish nursing home","authors":"H. Rodríguez Ramallo, E. Prado Mel, R. Ramos Romero, MI Galván-Borrás, JC Huarte Mendicoa, B. Fernandez Rubio","doi":"10.1136/EJHPHARM-2021-EAHPCONF.328","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.328","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76813329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-265 Cemiplimab for the treatment of relapse of a cutaneous squamous cell carcinoma in an adult patient: a case report 头孢米单抗治疗成人皮肤鳞状细胞癌复发1例
European Journal of Hospital Pharmacy: Science and Practice Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.97
J. D. Valencia, R. T. Bermejo, L. Rodelo, I. Castillo
{"title":"4CPS-265 Cemiplimab for the treatment of relapse of a cutaneous squamous cell carcinoma in an adult patient: a case report","authors":"J. D. Valencia, R. T. Bermejo, L. Rodelo, I. Castillo","doi":"10.1136/EJHPHARM-2021-EAHPCONF.97","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.97","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82969315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-124 Anticoagulation management within a hospital setting: identifying risk factors affecting patient safety 5PSQ-124医院环境中的抗凝管理:识别影响患者安全的危险因素
European Journal of Hospital Pharmacy: Science and Practice Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.243
K. Noerens, N Van Tittelboom, A Van Buyten, H. Vandekerckhove
{"title":"5PSQ-124 Anticoagulation management within a hospital setting: identifying risk factors affecting patient safety","authors":"K. Noerens, N Van Tittelboom, A Van Buyten, H. Vandekerckhove","doi":"10.1136/EJHPHARM-2021-EAHPCONF.243","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.243","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84115103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1ISG-025 Budget impact analysis of biosimilar adalimumab versus reference adalimumab 1ISG-025阿达木单抗与参考阿达木单抗生物仿制药的预算影响分析
European Journal of Hospital Pharmacy: Science and Practice Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.6
C. Morell, JM Gonzalez Puyuelo, Mp Monforte Gasque, N. L. Andújar, M. D. Olmo, E. Gallardo
{"title":"1ISG-025 Budget impact analysis of biosimilar adalimumab versus reference adalimumab","authors":"C. Morell, JM Gonzalez Puyuelo, Mp Monforte Gasque, N. L. Andújar, M. D. Olmo, E. Gallardo","doi":"10.1136/EJHPHARM-2021-EAHPCONF.6","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.6","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77998743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5PSQ-137 Adequacy of diagnosis and treatment of pharyngotonsillitis 5PSQ-137咽扁桃体炎诊治的充分性
European Journal of Hospital Pharmacy: Science and Practice Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.256
C. Salom, J. Blade, C. Campabadal, F. Bejarano, C. Torrente, M. Piqueras, N. Marco, L. Castillo, M. Roch, A. Sanjuan, L. Canadell
{"title":"5PSQ-137 Adequacy of diagnosis and treatment of pharyngotonsillitis","authors":"C. Salom, J. Blade, C. Campabadal, F. Bejarano, C. Torrente, M. Piqueras, N. Marco, L. Castillo, M. Roch, A. Sanjuan, L. Canadell","doi":"10.1136/EJHPHARM-2021-EAHPCONF.256","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.256","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82190225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-334 Influence of anthropometric, demographic and therapeutic factors on serum concentrations of anti-TNF drugs 人体测量学、人口学和治疗因素对血清抗tnf药物浓度的影响
European Journal of Hospital Pharmacy: Science and Practice Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.166
S. Giménez, J. Polo, A. Sendra, P. Llopis, M. Climente
{"title":"4CPS-334 Influence of anthropometric, demographic and therapeutic factors on serum concentrations of anti-TNF drugs","authors":"S. Giménez, J. Polo, A. Sendra, P. Llopis, M. Climente","doi":"10.1136/EJHPHARM-2021-EAHPCONF.166","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.166","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78703086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-372 Pharmaceutical interventions in hospitalised patients during the first wave of the SARS-CoV-2 pandemic 第一波SARS-CoV-2大流行期间住院患者的药物干预措施
European Journal of Hospital Pharmacy: Science and Practice Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.204
A. Sancho, B. García, A. Villaescusa, L. L. Lopez, J. Amigo, E. Albert, N. Martínez
{"title":"4CPS-372 Pharmaceutical interventions in hospitalised patients during the first wave of the SARS-CoV-2 pandemic","authors":"A. Sancho, B. García, A. Villaescusa, L. L. Lopez, J. Amigo, E. Albert, N. Martínez","doi":"10.1136/EJHPHARM-2021-EAHPCONF.204","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.204","url":null,"abstract":"Background and importanceThe activity of pharmacy services increased during the first wave of the SARS-Cov-2 pandemic An example of this was the activity carried out during the validation of inpatient treatments Aim and objectivesTo evaluate pharmaceutical interventions carried out in a second level hospital during the pandemic and compare them with those in the same period of the previous year Material and methodsThis was a retrospective study All pharmaceutical interventions between March and May 2020 (pandemic period: P) and those between March and May 2019 (pre-pandemic period: pre-P) were reviewed Data collected were: number of interventions, hospital stay, intervention rate (number of interventions × 1000 hospital stays), therapeutic group involved and type of intervention Data analysis: Stata V 15 1 The χ2 Mantel–Haenszel test was used to compare intervention rates and the χ2 Pearson to compare proportions ResultsThe number of interventions was 690 versus 115, and the number of hospital stays was 27 415 versus 27 062 for the P and pre-P periods, respectively The intervention rate (P vs pre-P) was 25 2×1000 stays versus 4 2×1000 stays (χ2 Mantel–Haenszel, p<0 0001) Therapeutic groups involved (P vs pre-P, respectively) were: P01-antiparasitics/hydroxychloroquine (40% vs 0%), J-01-antibiotics and J05-antivirals (17% vs 19%), N05-antipsychotics (7% vs 6%), B01-anticoagulants antiaggregants (6% vs 15%), N-02 analgesics (5% vs 21%) and other groups (25% vs 39%) Statistically significant differences were found between both distributions (χ2 Pearson, p<0,001) Type of interventions (P vs pre-P, respectively): drug interaction monitoring (40% vs 11%), stop treatment (26% vs 17%), dosage change (26% vs 60%) and other interventions (8% vs 12%) Both distributions (P and pre-P) were compared, and there were statistically significant differences between them (χ2 Pearson, p<0,001) Conclusion and relevanceDuring the first wave of the SARS-CoV-2 pandemic, activity related to the validation of inpatients treatments increased significantly in our centre The acceptance rate of interventions was not collected but it should be considered for future studies The therapeutic groups involved in the pharmaceutical interventions differed between the P and pre-P periods In the P period, those related to antiparasitic drugs (which includes hydroxychloroquine) increased significantly Types of interventions were also different between both periods In the P period, the interventions related to drug interactions and excessive durations of treatments were the most frequent Both types were interventions related to the safety of treatments during the pandemic References and/or acknowledgementsConflict of interestNo conflict of interest","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88999341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2SPD-037 Analysis of drug dispenses outside the hospital guide in a psychiatric hospital 2SPD-037某精神病院院外用药指南分析
European Journal of Hospital Pharmacy: Science and Practice Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.20
J. Costa, EM Robles Blazquez, Jm Gonzalez, M. Guzman
{"title":"2SPD-037 Analysis of drug dispenses outside the hospital guide in a psychiatric hospital","authors":"J. Costa, EM Robles Blazquez, Jm Gonzalez, M. Guzman","doi":"10.1136/EJHPHARM-2021-EAHPCONF.20","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.20","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"72 1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89173704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4CPS-297 Spinal cord aplasia caused by 6-mercaptopurine in a Caucasian girl with acute lymphoblastic leukaemia and homozygous mutation in nudix hydrolase 15: case report 6-巯基嘌呤致急性淋巴细胞白血病白种人女童脊髓发育不全并裸酶15纯合突变1例
European Journal of Hospital Pharmacy: Science and Practice Pub Date : 2021-03-01 DOI: 10.1136/EJHPHARM-2021-EAHPCONF.129
LE Pineda Lancheros, C. Pérez Ramírez, N. Moreno Toro, A. Espinosa Rodriguez, A. Sánchez Martín
{"title":"4CPS-297 Spinal cord aplasia caused by 6-mercaptopurine in a Caucasian girl with acute lymphoblastic leukaemia and homozygous mutation in nudix hydrolase 15: case report","authors":"LE Pineda Lancheros, C. Pérez Ramírez, N. Moreno Toro, A. Espinosa Rodriguez, A. Sánchez Martín","doi":"10.1136/EJHPHARM-2021-EAHPCONF.129","DOIUrl":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.129","url":null,"abstract":"","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"334 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79731357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信